Insider Transaction Report for NEUROCRINE BIOSCIENCES INC

Onyia Jude, Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC (NBIX), reported a series of transactions on May 27, 2026. Jude acquired 11,000 shares of Common Stock under a Rule 10b5-1 trading plan, with a weighted average price of $84.74 per share. Concurrently, Jude disposed of 11,000 shares of Common Stock at a weighted average price of $155.5332 per share, with individual sales ranging from $154.47 to $156.74. These dispositions were also executed via a Rule 10b5-1 trading plan. Additionally, Jude exercised a non-qualified stock option for 11,000 shares of Common Stock at an exercise price of $84.74 per share. Following these transactions, Jude directly owns 25,846 shares of Common Stock.